EME Medical
EME Medical › Drug encyclopedia

💊 Medroxyprogesterone (Medroxyprogesterone)

💊 Progestin hormone (progesterone derivative)

Medroxyprogesterone acetate tablets are a prescription progestin hormone. They are used to treat secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance, and to prevent endometrial hyperplasia in certain postmenopausal women taking estrogens. Your doctor determines the dose and duration of treatment.

🏷️ Brands: Medroxyprogesterone💉 Oral📋 Prescription only
In Arabic: ميدروكسي بروجستيرون (أسيتات ميدروكسي بروجستيرون)
Chemical structure of Medroxyprogesterone
ⓘ

🏷️ Brand names & manufacturers

Medroxyprogesterone — PharmPak, Inc.Medroxyprogesterone🏭 PharmPak, Inc.DailyMed
Packages shown are US-market (DailyMed). Brands available in Palestine are in the price section below.

✅ What it is used for

🧪 Active ingredient

The active substance is medroxyprogesterone acetate, a derivative of progesterone. In women with adequate endogenous estrogen, it transforms proliferative endometrium into secretory endometrium.

🌿 Benefits

📝 How to use

💊 Dosage forms

⚠️ Common side effects

  • Irregular uterine bleeding, spotting, changes in menstrual flow or amenorrhea
  • Breast tenderness or pain
  • Nausea
  • Headache, dizziness, insomnia, somnolence, nervousness
  • Mental depression
  • Weight changes, edema/fluid retention, fatigue
  • Acne, hair loss, excess hair growth

🚨 Serious — seek medical help

  • Blood clots (thrombophlebitis, pulmonary embolism, deep vein thrombosis)
  • Stroke and myocardial infarction
  • Severe allergic reactions (anaphylaxis, angioedema, urticaria, generalized rash)
  • Cholestatic jaundice (yellowing of skin or eyes)
  • Eye problems such as retinal thrombosis and optic neuritis
  • Decreased glucose tolerance

⛔ Do not use if

❗ Warnings & precautions

🔄 Drug interactions

🤰 Pregnancy

Pregnancy Category X: should not be used during pregnancy. There may be increased risks for hypospadias, clitoral enlargement and labial fusion in children exposed during the first trimester, although a clear association has not been established.

🍼 Breastfeeding

Should not be used during lactation; detectable amounts of progestin have been found in the breast milk of nursing mothers receiving progestins.

🧒 Children

Not indicated in children; clinical studies have not been conducted in the pediatric population.

👴 Older adults

There are not enough data in women over 65 to determine differences in response when used alone. In the WHI studies, women over 65 had a higher relative risk of nonfatal stroke and invasive breast cancer, and an increased risk of probable dementia was seen.

🌡️ Storage

Store at 20° to 25°C (68° to 77°F) in a tight, light-resistant container with a child-resistant closure, and keep out of the reach of children.

⏰ Missed dose

The label text provided gives no instructions for a missed dose; ask your doctor or pharmacist and do not double the dose on your own.

🆘 Overdose

Overdose may cause nausea and vomiting, breast tenderness, dizziness, abdominal pain, drowsiness/fatigue and withdrawal bleeding. Treatment is discontinuation with appropriate symptomatic care. Seek medical help immediately.

💰 Price & brands in your area

🏛️ Official price in Palestine — Ministry of Health price list:

ProductCompanyPackPrice
ORALUTE TAB.
MEDROXYPROGESTERONE ACETATE
BPC20 tab20 ₪
Source: pharmacy.moh.ps · list updated: 2026-11-10

📍 Find the nearest pharmacy

Your location is used only in your browser to show nearby pharmacies — we don't store it.

Open in Google Maps

👨‍⚕️ For healthcare professionals

Mechanism of action

MPA transforms proliferative into secretory endometrium in women with adequate endogenous estrogen. Androgenic and anabolic effects are noted, with no significant estrogenic activity. Parenteral MPA inhibits gonadotropin production and ovulation, but this does not occur with the usual recommended oral dosage given as single daily doses. It is rapidly absorbed from the GI tract with peak concentrations at 2 to 4 hours; food increases bioavailability.

Labeled dosing

Per label, general adult dosing: Secondary amenorrhea: 5 or 10 mg daily for 5 to 10 days (10 mg daily for 10 days for optimum secretory transformation). Abnormal uterine bleeding: 5 or 10 mg daily for 5 to 10 days beginning on the calculated 16th or 21st day of the cycle. Prevention of endometrial hyperplasia in postmenopausal women on 0.625 mg conjugated estrogens: 5 or 10 mg daily for 12 to 14 consecutive days per month, starting day 1 or day 16 of the cycle, beginning with the lowest dose. The final dose is determined by the prescriber.

🎓 Key points for students

🩺 Run a clinic or medical center?

EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.

Try EME free   How we protect your data

❓ FAQ

Why is medroxyprogesterone prescribed?

To treat secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance, and to prevent endometrial hyperplasia in postmenopausal women taking estrogen.

When does bleeding occur after stopping the medicine?

Withdrawal bleeding usually occurs within 3 to 7 days after stopping therapy.

Can it be used during pregnancy?

No. It is Pregnancy Category X and contraindicated in known or suspected pregnancy.

Can it be used while breastfeeding?

It should not be used during lactation because progestin passes into breast milk.

What are the most serious side effects?

Blood clots, stroke, heart attack and breast cancer when used with estrogen, and severe allergic reactions. Tell your doctor immediately if worrying symptoms appear.

⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2022-10), simplified. Updated: 2026-11-15.